- Home
- FL vs OGN Comparison
FL vs OGN Comparison
Compare FL & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FL
- OGN
- Stock Information
- Founded
- FL 1879
- OGN 1923
- Country
- FL United States
- OGN United States
- Employees
- FL N/A
- OGN N/A
- Industry
- FL Clothing/Shoe/Accessory Stores
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- FL Consumer Discretionary
- OGN Health Care
- Exchange
- FL Nasdaq
- OGN Nasdaq
- Market Cap
- FL 2.3B
- OGN 2.5B
- IPO Year
- FL N/A
- OGN N/A
- Fundamental
- Price
- FL $23.98
- OGN $9.76
- Analyst Decision
- FL Hold
- OGN Hold
- Analyst Count
- FL 15
- OGN 4
- Target Price
- FL $21.00
- OGN $18.00
- AVG Volume (30 Days)
- FL 3.9M
- OGN 4.7M
- Earning Date
- FL 05-29-2025
- OGN 08-05-2025
- Dividend Yield
- FL N/A
- OGN 8.82%
- EPS Growth
- FL N/A
- OGN N/A
- EPS
- FL N/A
- OGN 2.88
- Revenue
- FL $7,903,000,000.00
- OGN $6,294,000,000.00
- Revenue This Year
- FL $1.29
- OGN N/A
- Revenue Next Year
- FL $2.31
- OGN $1.11
- P/E Ratio
- FL N/A
- OGN $3.39
- Revenue Growth
- FL N/A
- OGN N/A
- 52 Week Low
- FL $11.00
- OGN $8.01
- 52 Week High
- FL $33.94
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- FL 74.97
- OGN 49.46
- Support Level
- FL $23.90
- OGN $9.88
- Resistance Level
- FL $24.19
- OGN $10.30
- Average True Range (ATR)
- FL 0.16
- OGN 0.38
- MACD
- FL -0.39
- OGN 0.11
- Stochastic Oscillator
- FL 46.87
- OGN 60.66
About FL Foot Locker Inc.
Foot Locker Inc operates footwear and apparel retailer in North America, Europe, Australia, New Zealand, and Asia, and has licensed store presence in the Middle East, Europe, and Asia. The company mainly sells athletically inspired shoes and apparel. Foot Locker's merchandise comes from only a few suppliers, with Nike providing the majority. Its portfolio of brands includes Foot Locker, Kids Foot Locker, Champs Sports, WSS, and atmos. The company has omnichannel capabilities to bridge the digital world and physical stores, including order-in-store, buy online and pickup-in-store, and buy online and ship-from-store, as well as e-commerce. It has three operating segments, North America, EMEA, and Asia Pacific.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.